CAS: 603987-35-5 - E6201
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | 1H-2-Benzoxacyclotetradecin-1,7(8H)-dione, 14-(ethylamino)-3,4,9,10-tetrahydro-8,9,16-trihydroxy-3,4-dimethyl-, (3S,4R,5Z,8S,9S,11E) REF: 3D-FB145171CAS: 603987-35-5 | Min. 95% | Prezzo su richiesta | Gio 19 Dic 24 |
 | E6201 REF: TM-T61755CAS: 603987-35-5 | - - - | 1.437,00 €~2.364,00 € | Mar 11 Mar 25 |
1H-2-Benzoxacyclotetradecin-1,7(8H)-dione, 14-(ethylamino)-3,4,9,10-tetrahydro-8,9,16-trihydroxy-3,4-dimethyl-, (3S,4R,5Z,8S,9S,11E)
CAS:603987-35-5
Please enquire for more information about 1H-2-Benzoxacyclotetradecin-1,7(8H)-dione, 14-(ethylamino)-3,4,9,10-tetrahydro-8,9,16-trihydroxy-3,4-dimethyl-, (3S,4R,5Z,8S,9S,11E) including the price, delivery time and …
Formula:
C21H27NO6
Purezza:
Min. 95%
Peso molecolare:
389.44 g/mol
Ref: 3D-FB145171
| Dimensione non definita | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Giovedì 19 Dicembre 2024
E6201
CAS:603987-35-5
E6201, a dual kinase inhibitor, blocks MEK1/FLT3 and has anti-tumor/psoriasis effects with low IC50s: ERK2 …
Formula:
C21H27NO6
Colore e forma:
Liquid
Peso molecolare:
389.44
Ref: TM-T61755
| 25mg | 1.437,00 € | ||
| 50mg | 1.872,00 € | ||
| 100mg | 2.364,00 € |
Consegna stimata in Stati Uniti, il Martedì 11 Marzo 2025
